Alan Lenox‐Smith
Impact in
- Pharmacology top 5%
- Treatment of Major Depression
Papers in
- Pharmacology 10
- Treatment of Major Depression 10
-
- Dementia and Cognitive Impairment Research 4
- Electroconvulsive Therapy Studies 2
- Co-authors
- Qin Jiang (1 shared paper)Alan Reynolds (1 shared paper)Catherine Reed (7 shared papers)Mark Belger (5 shared papers)David Taylor (1 shared paper)Andrew Bradley (1 shared paper)Michael Happich (3 shared papers)Jérémie Lebrec (2 shared papers)
- Journals
- BMC Geriatrics (3 papers)PharmacoEconomics (2 papers)European Neuropsychopharmacology (2 papers)Journal of Psychopharmacology (2 papers)The European Journal of Health Economics (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Alan Lenox‐Smith
26 papers receiving 475 citations
Peers
Comparison fields: 5 of 70
- Pharmacology 164
- Biological Psychiatry 23
- Psychiatry and Mental health 134
- Experimental and Cognitive Psychology 102
- Behavioral Neuroscience 14
Countries citing papers authored by Alan Lenox‐Smith
This map shows the geographic impact of Alan Lenox‐Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Lenox‐Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Lenox‐Smith more than expected).
Fields of papers citing papers by Alan Lenox‐Smith
This network shows the impact of papers produced by Alan Lenox‐Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Lenox‐Smith. The network helps show where Alan Lenox‐Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Lenox‐Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 53 | |
| 2 | A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care. | 2003 | 45 |
| 3 | 2014 | 38 | |
| 4 | 2014 | 34 | |
| 5 | 2013 | 30 | |
| 6 | 2013 | 29 | |
| 7 | 2015 | 28 | |
| 8 | 2014 | 26 | |
| 9 | 2000 | 25 | |
| 10 | 2016 | 24 | |
| 11 | 2004 | 23 | |
| 12 | 2018 | 21 | |
| 13 | 2013 | 20 | |
| 14 | 2010 | 19 | |
| 15 | 2014 | 19 | |
| 16 | 2016 | 15 | |
| 17 | 2005 | 13 | |
| 18 | 2009 | 12 | |
| 19 | 2014 | 9 | |
| 20 | 2018 | 6 |
About Alan Lenox‐Smith
Alan Lenox‐Smith is a scholar working on Pharmacology, Psychiatry and Mental health, Experimental and Cognitive Psychology, Cellular and Molecular Neuroscience and Clinical Psychology, having authored 26 papers that have together received 507 indexed citations. Recurring topics across this work include Treatment of Major Depression (10 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers), Dementia and Cognitive Impairment Research (4 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Child and Adolescent Psychosocial and Emotional Development (2 papers), Mental Health Research Topics (2 papers), Pain Mechanisms and Treatments (2 papers) and Electroconvulsive Therapy Studies (2 papers). The work is most often cited by research in Pharmacology (164 citations), Biological Psychiatry (23 citations), Psychiatry and Mental health (134 citations), Experimental and Cognitive Psychology (102 citations) and Behavioral Neuroscience (14 citations). Alan Lenox‐Smith has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Qin Jiang, Alan Reynolds, Catherine Reed, Mark Belger, David Taylor, Andrew Bradley, Michael Happich, Jérémie Lebrec, Roy Jones and Lei Chen. Their work appears in journals such as BMC Geriatrics, PharmacoEconomics, European Neuropsychopharmacology, Journal of Psychopharmacology and The European Journal of Health Economics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.